{"article_title": "How Illinois Allocates $84,000 Drug for Hepatitis C", "article_keywords": ["treating", "84000", "c", "stringent", "society", "sparked", "allocates", "drug", "illinois", "sovaldi", "state", "hepatitis", "using", "value", "stage", "treatment"], "article_url": "http://www.wsj.com/articles/how-illinois-allocates-84-000-drug-for-hepatitis-c-1407114940", "article_text": "The $84,000-a-patient cost of the Sovaldi hepatitis C treatment has intensified a national debate among lawmakers, insurers and economists about the value of expensive medicines to society at large. The dilemma sparked by Sovaldi, which is made by Gilead Sciences, is also presenting hard choices to state Medicaid programs. In Illinois, for instance, officials recently instituted a new set of 25 stringent criteria for using Sovaldi that includes treating only those patients with the most advanced stage of liver disease and...", "article_metadata": {"article.template": "snippet", "article.created": "2014-08-04T01:15:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "The high per-patient cost of the Sovaldi treatment has required Illinois to set stringent criteria, explains Arvind Goyal, a state health official.", "title": "How Illinois Allocates $84,000 Drug for Hepatitis C", "image": {"alt": "How Illinois allocates an $84,000-a-patient drug that treats hepatitis C", "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif"}, "creator": "@pharmalot", "site": "@WSJ", "card": "summary"}, "al": {"ios": {"url": "wsj://launch?articleid=SB10001424052702304635104580063722861694154&headline=How%20Illinois%20allocates%20an%20%2484%2C000-a-patient%20drug%20that%20treats%20hepatitis%20C&weburl=http://www.wsj.com/articles/SB10001424052702304635104580063722861694154"}}, "page.site.product": "WSJ", "keywords": "drug rationing,expensive drugs,expensive hepatitis drug,expensive hep c,expensive medications,gilead sciences,healthcare rationing,medicaid,solvaldi,treating hepatitis c,Gilead Sciences,GILD,Arvind Goyal,corporate,industrial news,drug,substance usage,addictions,alcoholism,political,general news,society,community,work,health,hepatitis,medical conditions,mental health,social issues,medical treatments,procedures,biotechnology,pharmaceuticals,health care,life sciences,biopharmaceuticals,drugs,medication", "news_keywords": "drug rationing,expensive drugs,expensive hepatitis drug,expensive hep c,expensive medications,gilead sciences,healthcare rationing,medicaid,solvaldi,treating hepatitis c", "article.headline": "How Illinois allocates an $84,000-a-patient drug that treats hepatitis C", "description": "The high per-patient cost of the Sovaldi treatment has required Illinois to set stringent criteria, explains Arvind Goyal, a state health official.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB10001424052702304635104580063722861694154&headline=How%20Illinois%20allocates%20an%20%2484%2C000-a-patient%20drug%20that%20treats%20hepatitis%20C&weburl=http://www.wsj.com/articles/SB10001424052702304635104580063722861694154", "user.type": "nonsubscriber", "testkeys": "A", "article.page": "News", "article.summary": "The high per-patient cost of the Sovaldi treatment has required Illinois to set stringent criteria, explains Arvind Goyal, a state health official.", "page.site": "wsj", "page.content.format": "responsive", "article.published": "2014-08-04T01:15:00.000Z", "dj.asn": "i-e962", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"internal_link_count": 1, "word_count": 1029, "publisher": "https://www.facebook.com/wsj"}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "The high per-patient cost of the Sovaldi treatment has required Illinois to set stringent criteria, explains Arvind Goyal, a state health official.", "title": "How Illinois Allocates $84,000 Drug for Hepatitis C", "url": "http://www.wsj.com/articles/how-illinois-allocates-84-000-drug-for-hepatitis-c-1407114940", "image": {"width": 1200, "identifier": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "height": 630}, "locale": "en_US", "type": "article"}, "author": "Ed Silverman", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "How Illinois Allocates $84,000 Drug for Hepatitis C", "article.type": "Business", "article.id": "SB10001424052702304635104580063722861694154", "user.exp": "default", "article.updated": "2014-08-04T01:15:00.000Z"}, "_id": "\"57477af46914bd0286fe430b\"", "article_summary": "The dilemma sparked by Sovaldi, which is made by Gilead Sciences, is also presenting hard choices to state Medicaid programs.\nThe $84,000-a-patient cost of the Sovaldi hepatitis C treatment has intensified a national debate among lawmakers, insurers and economists about the value of expensive medicines to society at large.\nIn Illinois, for instance, officials recently instituted a new set of 25 stringent criteria for using Sovaldi that includes treating only those patients with the most advanced stage of liver disease and..."}